Cargando…
Nano‐calcipotriol as a potent anti‐hepatic fibrosis agent
Calcipotriol (CAL) has been widely studied as a fibrosis inhibitor and used to treat plaque psoriasis via transdermal administration. The clinical application of CAL to treat liver fibrosis is bottlenecked by its unsatisfactory pharmacokinetics, biodistribution, and side effects, such as hypercalcem...
Autores principales: | Zhang, Yina, Wang, Liying, Shao, Jiajia, Liu, Yanning, Lu, Yining, Yang, Jing, Xu, Siduo, Zhang, Jingkang, Li, Minwei, Liu, Xiangrui, Zheng, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458662/ https://www.ncbi.nlm.nih.gov/pubmed/37638336 http://dx.doi.org/10.1002/mco2.354 |
Ejemplares similares
-
The Crosstalk Between Regulatory Non-Coding RNAs and Nuclear Factor Kappa B in Hepatocellular Carcinoma
por: Zhang, Yina, et al.
Publicado: (2021) -
Calcipotriol attenuates liver fibrosis through the inhibition of vitamin D receptor-mediated NF-κB signaling pathway
por: Gong, Jian, et al.
Publicado: (2022) -
ROS-sensitive calcipotriol nano-micelles prepared by methoxypolyethylene glycol (mPEG) – modified polymer for the treatment of psoriasis
por: Hua, Yulin, et al.
Publicado: (2022) -
Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris
por: Vakirlis, Efstratios, et al.
Publicado: (2008) -
Successful Treatment of Alopecia Areata with Topical Calcipotriol
por: Kim, Dong Ha, et al.
Publicado: (2012)